Based on the initial 5 million units shipped and subsequent sales - it may be enough for Novartis to recover their costs in 1-2 quarters at most. dont you agree?
IF DD's range is correct, then yes.
I have not done the work to properly estimate the amounts reimbursable. My guess is higher than DD but then he has some basis for his numbers. :-)